Emlin BioScience Exchange
Retatrutide
Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Emlin BioScience Exchange between 12 Mar 2026 and 3 Aug 2026. Test scores average over 7, no score below 6, and at least 6 tests warrant a confident Finnrick Rating of A (Great).
Finnrick Rating™
Emlin BioScience Exchange
Retatrutide
Tested 6 Samples
Last test 3 Aug 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Emlin BioScience Exchange
Samples are tested in commercial labs
Tests Count
6
Scores
AVGMINMAX
Last
3 Aug 2026
First
12 Mar 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 3 Aug 2026 | View | 20mg | 18.4mg | -8.0% | 99.90% | RT20/20260420 | No label / Silver crimp / Clear Green cap | Lab E | Public | |
| 30 Jul 2026 | View | 20mg | 21.2mg | +6.0% | 99.70% | RT20 | No label / Silver crimp / Clear Green cap | Lab G | Public | |
| 30 Jul 2026 | View | 30mg | 30.7mg | +2.3% | 99.80% | RT30 | No Label / Silver Crimp / Clear Yellow Cap | Lab G | Public | |
| 12 Jun 2026 | View | 10mg | 10.6mg | +6.0% | 99.60% | 2026-0101 | Pink label / Silver crimp / Yellow cap | Lab G | Public | |
| 6 Jun 2026 | View | 10mg | 10mg | 99.70% | RT10-01-30-2028 | Black label / Silver crimp / No cap | Lab G | Public | ||
| 12 Mar 2026 | View | 10mg | 10.1mg | +1.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |